Delivery Order SPE2DB25D3005-SPE2DB25FQBFN

Award Date 12/19/24
Potential Completion Date 12/20/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQBFN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,358.93 firm fixed-price delivery order is for the supply of 4566770986 - ADVAIR HFA 230-21 MCG INHALER 12GM, a respiratory medication. The contract has an ultimate completion date of December 20, 2024 and was awarded on December 19, 2024.

Amerisourcebergen is the prime contractor for this award, which is not designated as a set-aside contract. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, both of which cover a wide range of pharmaceutical and medical supply products to support federal healthcare programs. This contract award demonstrates Amerisourcebergen's significant role as a key vendor for providing essential medical commodities to the U.S. military, veterans, and other federal beneficiaries.

Generated 3/20/25, 9:49 AM